912 results on '"Reuter, Uwe"'
Search Results
2. Setup for ML-Based Prediction of Concrete Rheology from 3D Slump Test Geometry
3. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol
4. PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study
5. Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies – insights from the German NeuroTransData registry
6. Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study
7. Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
8. Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030
9. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
10. Serum tau protein elevation in migraine: a cross-sectional case–control study
11. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
12. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment
13. The sense of stopping migraine prophylaxis
14. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis
15. Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
16. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
17. A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
18. Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
19. Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2–4 Prior Preventive Treatments Had Failed
20. Deep learning fuzzy immersion and invariance control for type-I diabetes
21. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
22. Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
23. Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
24. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
25. Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
26. Galcanezumab
27. A novel approach for automatic detection of linear and nonlinear dependencies between data by means of autoencoders
28. Erenumab versus topiramate: migraine‐related disability, impact and health‐related quality of life.
29. Translation of Multidimensional Health Locus of Control Scales, Form C in Patients with Headache.
30. Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial
31. Structural optimization of transmission towers using a novel Genetic Algorithm approach with a variable length genome
32. Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
33. Diagnosis and management of migraine in ten steps
34. Prevalence and characteristics of rapid eye movement sleep behaviour disorder in adults with migraine: a cross‐sectional screening study.
35. Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
36. Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies
37. Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary
38. Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial
39. CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
40. Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials
41. Galcanezumab
42. Perception of typical migraine images on the internet: Comparison between a metropolis and a smaller rural city in Germany
43. 2631 Early onset of efficacy with Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS trial
44. Near‐death experiences are associated with REM sleep intrusion in migraine patients, independent of migraine aura
45. Serum tau protein elevation in migraine: a cross-sectional case- control study
46. Analyse und Korrektur des geometrischen und thermischen Einflusses auf Einspritzratenmessungen bei Einsatz eines leitungsbasierten Messsystems
47. A comparative study of machine learning approaches for modeling concrete failure surfaces
48. European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
49. A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response
50. Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.